Product
Rhu-pGSN
Aliases
recombinant human gelsolin
1 clinical trial
2 indications
Indication
Acute Respiratory Distress SyndromeIndication
InfectionsClinical trial
A Phase 2 Randomized Double-blind Placebo-controlled Study To Evaluate The Efficacy And Safety Of Adjunctive Recombinant Human Plasma Gelsolin With Standard Care For Moderate-to-Severe ARDS Due To Pneumonia Or Other InfectionsStatus: Not yet recruiting, Estimated PCD: 2025-10-01